Minnesota 12-year-old is first in new trial of drug to treat rare, crippling disorder
Gillette Children's Specialty Healthcare in St. Paul was first to set up special program for providing still-experimental drug against Duchenne muscular dystrophy.
More from Minnesota Business
Star Tribune Business
War made planting difficult. Now it could boost farmers' profits.
Minnesota Business
•
7h ago
Star Tribune Business
Ramstad: Fraud in Minnesota has not cost $9 billion, but it's hurt more
Minnesota Business
•
1d ago
Star Tribune Business
Summit Brewing could avoid foreclosure with new lender
Minnesota Business
•
2d ago
Star Tribune Business
Watch the replays of the North Star Summit sessions
Minnesota Business
•
3d ago